[Transcutaneous bilirubinometry and early hospital discharge in low risk newborns with jaundice].
BACKGROUND
Discharge soon after birth and beginning of therapeutic interventions in jaundiced newborns depends on the assessment of bilirubin serum levels.


OBJECTIVE
The comparison between total bilirubin serum levels with transcutaneous bilirubin levels and evaluate utility of a hand held device to measure transcutaneous bilirubin as a diagnostic tool to predict early discharge.


METHODS
Transversal, prolective study. Near simultaneous measurements of serum and transcutaneous bilirubin was undertaken in newborns with birth weight > 2000 grams, gestational age > 36 weeks and extrauterine life under 72 hours.


RESULTS
100 newborns were enrolled, with birth weight 3,135 +/- 499.9 grams, gestational age of 38.85 +/- 1.4 weeks and 45.46 +/- 1.75 hours of life at the time of bilirubin measurement. Correlation coefficient was 0.81 (p < 0.0001).


CONCLUSIONS
Predischarge quantification of jaundice by transcutaneous bilirubin should be performed in all healthy newborns. Levels under 4.9 mg/dL within first 24 hours of life and values under 7.9 mg/dL between 48 to 72 hours, were considered safely to allow early discharge in newborns studied.
Unidad de Cuidados Intensivos Neonatales, Hospital de Gineco-Obstetricia Luis Castelazo Ayala IMSS.
J A
JA
Corzo Pineda
V H
VH
Jurado Hernández
J L
JL
Tejera Orozco
M O
MO
Martínez González
D001663:Bilirubin / Q000097:blood*; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000175:diagnosis*; D010351:Patient Discharge; D019095:Point-of-Care Systems; D012044:Regression Analysis
D001663:Bilirubin